Amylyx will be allowed to run a Phase I trial after the FDA lifted a clinical hold of its investigational ALS drug.
Synthetic chemicals called per- and polyfluoroalkyl substances (PFAS) have been accumulating in the environment since their ...
Valneva has announced positive outcomes from its Phase III trial of the single-shot IXCHIQ chikungunya virus vaccine in ...